Merck Sharp & Dohme (MSD) a US pharmaceutical company and one of the largest pharmaceutical companies in the world, has introduced Singulair, a drug that treats asthma and allergic rhinitis in children and adults. In a bid to drive access to its medicines globally, MSD launched its leukotriene receptor antagonist, Singulair (MSD brand of Montelukast ...
Read Full Story
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS